MedTrace Logo

Intervention Study of Drugs in Patients Osteopenia and Osteoporosis

NCT04719572 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2021-01-25

No results posted yet for this study

Summary

This is a 12 months, randomized, multicenter, open-label, parallel-group study in postmenopausal women and male aged 50 years or old with osteoporosis or osteopenia in China to evaluate the efficacy and safety of different anti-osteoporpsis intervention strategies.

Conditions

Interventions

OTHER

Basic treatment group

A total of 60 subjects were recruited in the group.

OTHER

Basic treatment+ anti-osteoporosis drug group

A total of 60 subjects were recruited in the group.

OTHER

Basic treatment + non-drug treatment group

A total of 60 subjects were recruited in the group.

Sponsors & Collaborators

  • Beijing Jishuitan Hospital

    collaborator OTHER

  • Beijing Aerospace General Hospital

    collaborator OTHER

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Chunlin Li, M.D&Ph.D · PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-09-30
Completion
2023-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719572 on ClinicalTrials.gov